This inventor holds 1 USPTO granted patent. Top assignees: Ardan Pharma S.A.S., Institut Pasteur De Montevideo, Universidad De La Republica Oriental Del Uruguay. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Álvaro Mombrú: Innovator in Anti-Tumoral Treatments
Introduction
Álvaro Mombrú is a notable inventor based in Montevideo, Uruguay. He has made significant contributions to the field of medical science, particularly in the development of anti-tumoral therapies. His innovative approach focuses on enhancing the efficacy of treatments for neoplastic pathologies.
Latest Patents
Mombrú holds a patent titled "Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers." This invention is aimed at creating an anti-tumoral composition for the treatment of malignant neoplastic pathologies, including eg7 thymic lymphoma. The composition features a TMEM176A/B inhibitor formulated in nanoparticles, which is designed to improve treatment outcomes. The method involves administering this inhibitor to a subject, showcasing a novel approach to combating cancer.
Career Highlights
Throughout his career, Álvaro Mombrú has worked with prominent organizations such as Ardan Pharma S.A.S. and Universidad De La República Oriental Del Uruguay. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in anti-tumoral therapies.
Collaborations
Some of his notable coworkers include Marcelo Rafael Hill Mongabure and Mercedes Segovia. Their collaborative efforts have contributed to advancements in the understanding and treatment of cancer.
Conclusion
Álvaro Mombrú's work in developing innovative anti-tumoral treatments highlights his commitment to improving cancer therapies. His patent and collaborations reflect a dedication to advancing medical science for the benefit of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile